Yoosoo Yang

5.3k total citations · 2 hit papers
82 papers, 4.3k citations indexed

About

Yoosoo Yang is a scholar working on Molecular Biology, Immunology and Cell Biology. According to data from OpenAlex, Yoosoo Yang has authored 82 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 23 papers in Immunology and 17 papers in Cell Biology. Recurrent topics in Yoosoo Yang's work include Extracellular vesicles in disease (27 papers), RNA Interference and Gene Delivery (24 papers) and Cellular transport and secretion (16 papers). Yoosoo Yang is often cited by papers focused on Extracellular vesicles in disease (27 papers), RNA Interference and Gene Delivery (24 papers) and Cellular transport and secretion (16 papers). Yoosoo Yang collaborates with scholars based in South Korea, United States and Japan. Yoosoo Yang's co-authors include Yeonsun Hong, Sun Hwa Kim, Hyo‐Suk Kim, In‐San Kim, Gi‐Hoon Nam, Ick Chan Kwon, Gijung Kwak, Eunji Cho, Seung Ja Oh and Gi Beom Kim and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Yoosoo Yang

79 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosome‐Guided Phenotypic Switch of M1 to M2 Macrophages for Cutaneous Wound Healing

2019 443 citations Hyo‐Suk Kim, Gijung Kwak et al. Advanced Science profile →
Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting

2017 390 citations Yoosoo Yang, Yeonsun Hong et al. Journal of Controlled Release profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoosoo Yang South Korea	35	2.8k	1.1k	892	827	461	82	4.3k
Chen‐Hsiang Kuan Taiwan	14	2.4k 0.9×	657 0.6×	541 0.6×	1.5k 1.9×	587 1.3×	36	5.2k
Li Sun China	41	2.6k 0.9×	1.3k 1.2×	295 0.3×	637 0.8×	259 0.6×	153	4.8k
Alexander V. Ljubimov United States	45	1.9k 0.7×	537 0.5×	350 0.4×	269 0.3×	452 1.0×	124	6.2k
Bent Brachvogel Germany	29	1.6k 0.6×	436 0.4×	244 0.3×	630 0.8×	255 0.6×	83	3.5k
Michele Cilli Italy	37	2.0k 0.7×	658 0.6×	439 0.5×	658 0.8×	426 0.9×	108	4.0k
Khalid Shah United States	51	4.7k 1.7×	1.3k 1.2×	1.2k 1.4×	1.1k 1.3×	548 1.2×	139	8.5k
Annapoorni Rangarajan India	34	2.6k 0.9×	866 0.8×	542 0.6×	330 0.4×	311 0.7×	74	4.4k
Di Wen China	38	2.0k 0.7×	389 0.4×	2.0k 2.3×	1.5k 1.8×	901 2.0×	75	5.8k
Victoria Petkova United States	23	1.6k 0.6×	529 0.5×	287 0.3×	1.1k 1.4×	256 0.6×	28	3.6k

Countries citing papers authored by Yoosoo Yang

Since Specialization

Citations

This map shows the geographic impact of Yoosoo Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoosoo Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoosoo Yang more than expected).

Fields of papers citing papers by Yoosoo Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoosoo Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoosoo Yang. The network helps show where Yoosoo Yang may publish in the future.

Co-authorship network of co-authors of Yoosoo Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yoosoo Yang. A scholar is included among the top collaborators of Yoosoo Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoosoo Yang. Yoosoo Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Daeho, Hochung Jang, Yoon Sook Ko, et al.. (2025). Repurposing mesalamine for acute kidney injury through supramolecular assembly. Journal of Controlled Release. 385. 114041–114041.

Choi, Jiwoong, Jung Yeon Park, Jung-Suk Goo, et al.. (2025). Activatable PROTAC nanoassembly for photodynamic PTP1B proteolysis enhances glioblastoma immunotherapy. Acta Pharmaceutica Sinica B. 15(9). 4886–4899. 1 indexed citations

Choi, Ji‐Woong, Ansoo Lee, In‐Cheol Sun, et al.. (2025). Reprogramming of cancer metabolism via photoresponsive nano-PROTAC enhances pyroptosis-mediated immunotherapy. Signal Transduction and Targeted Therapy. 10(1). 310–310. 1 indexed citations

Jang, Hochung, Daeho Park, Yoon Sook Ko, et al.. (2025). Oral PTP1B siRNA Delivery Using Milk-Derived Extracellular Vesicles for Alleviation of Acute Kidney Injury. ACS Nano. 19(46). 40085–40099.

Choi, Jiwoong, Su Hyun Kim, Man Kyu Shim, et al.. (2025). Apolipoprotein Fusion Enables Spontaneous Functionalization of mRNA Lipid Nanoparticles with Antibody for Targeted Cancer Therapy. ACS Nano. 19(6). 6412–6425. 10 indexed citations

Han, Geonhee, Jong Won Lee, Jung Yeon Park, et al.. (2024). Mucoadhesive Mesalamine Prodrug Nanoassemblies to Target Intestinal Macrophages for the Treatment of Inflammatory Bowel Disease. ACS Nano. 18(25). 16297–16311. 19 indexed citations

Lee, Jong Won, Hong Yeol Yoon, Sukyung Song, et al.. (2024). Dual-Action Protein-siRNA Conjugates for Targeted Disruption of CD47-Signal Regulatory Protein α Axis in Cancer Therapy. ACS Nano. 18(33). 22298–22315. 3 indexed citations

Choi, Jiwoong, Jung Yeon Park, Hong Yeol Yoon, et al.. (2024). Light‐Triggered PROTAC Nanoassemblies for Photodynamic IDO Proteolysis in Cancer Immunotherapy. Advanced Materials. 36(38). e2405475–e2405475. 38 indexed citations

Lee, Jong Won, et al.. (2023). Design of siRNA Bioconjugates for Efficient Control of Cancer-Associated Membrane Receptors. ACS Omega. 8(39). 36435–36448. 5 indexed citations

10.

Kim, Hyo‐Suk, Byeong‐Wook Song, Soon‐Jung Park, et al.. (2022). Ultraefficient extracellular vesicle–guided direct reprogramming of fibroblasts into functional cardiomyocytes. Science Advances. 8(8). eabj6621–eabj6621. 23 indexed citations

11.

Kim, Hyo‐Suk, Eun Hye Kim, Hochung Jang, et al.. (2022). The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells. Pharmaceutics. 14(6). 1271–1271. 36 indexed citations

12.

Han, Geonhee, Hyo‐Suk Kim, Da Eun Kim, et al.. (2022). The Potential of Bovine Colostrum-Derived Exosomes to Repair Aged and Damaged Skin Cells. Pharmaceutics. 14(2). 307–307. 45 indexed citations

13.

Kwak, Gijung, Jing Cheng, Hyo‐Suk Kim, et al.. (2022). Sustained Exosome‐Guided Macrophage Polarization Using Hydrolytically Degradable PEG Hydrogels for Cutaneous Wound Healing: Identification of Key Proteins and MiRNAs, and Sustained Release Formulation. Small. 18(15). e2200060–e2200060. 110 indexed citations

14.

Kim, Hyo‐Suk, Geonhee Han, Su Jin Lee, et al.. (2022). Extracellular vesicle-guided in situ reprogramming of synovial macrophages for the treatment of rheumatoid arthritis. Biomaterials. 286. 121578–121578. 45 indexed citations

15.

Han, Geonhee, Hyo‐Suk Kim, Hochung Jang, et al.. (2022). Bovine colostrum derived-exosomes prevent dextran sulfate sodium-induced intestinal colitis via suppression of inflammation and oxidative stress. Biomaterials Science. 10(8). 2076–2087. 48 indexed citations

16.

Kim, Hyo‐Suk, Hyun‐Ju Park, Hyo Won Chang, et al.. (2022). Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer. Bioactive Materials. 25. 527–540. 42 indexed citations

17.

Kwak, Gijung, Hyo‐Suk Kim, Jooho Park, et al.. (2021). A Trojan-Horse Strategy by In Situ Piggybacking onto Endogenous Albumin for Tumor-Specific Neutralization of Oncogenic MicroRNA. ACS Nano. 15(7). 11369–11384. 30 indexed citations

18.

Kim, Hyo‐Suk, et al.. (2019). Exosome‐Guided Phenotypic Switch of M1 to M2 Macrophages for Cutaneous Wound Healing. Advanced Science. 6(20). 1900513–1900513. 443 indexed citations breakdown →

19.

Hong, Yongmiao, Gi‐Hoon Nam, Sangmin Jeon, et al.. (2017). Exosome as a Vehicle for Delivery of Membrane Protein Therapeutics, PH20, for Enhanced Tumor Penetration and Antitumor Efficacy. Advanced Functional Materials. 28(5). 111 indexed citations

20.

Lee, Jooyoung, Jae Won Kyung, Yoosoo Yang, et al.. (2016). Inositol pyrophosphates inhibit synaptotagmin-dependent exocytosis. Proceedings of the National Academy of Sciences. 113(29). 8314–8319. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact